The present invention relates, in general, to cancer therapy, and, in
particular, to a method of preventing or treating cancer using low
molecular weight antioxidants (e.g., mimetics of superoxide dismutase
(SOD)) as the active agent or as a chemo- and/or radio-protectant. The
invention also relates to compounds and compositions suitable for use in
such a method.